HERON THERAPEUTICS, INC. /DE/ - 10-Q Filing
Heron Therapeutics filed a Form 10-Q for the quarter ended March 31, 2026. The filing includes financial data and disclosures related to its operations, including revenue recognition, research and development expenses, accounts receivable concentration risks from major customers, and details about convertible notes issued in prior years.
Tickers: $HRTX